Growth in Patients reporting Eye Discomfort and Reduced Vision Problems along with Increasing Proportion of Elderly Citizens Population has Stimulated Growth in Ophthalmology Market in Malaysia: Ken Research

0


Lower Ophthalmology Costs in Malaysia: Ophthalmology cost in Malaysia is estimated to be comparatively less i.e. 40% less or even more than the spending made by a patient on an average for the same treatment in the US and European countries such as the UK, France, Germany and others. Low cost of Ophthalmology in Malaysia allows patients from the other countries to save a significant amount of money while benefiting from the one among the world-class medical treatment.

Hence, Malaysia is witnessing Growth in Number of Healthcare Travelers increased from 921 Thousand in 2016 to 1.2 Million in 2018, i.e. a growth of 14.1% during the period of just 2 years, i.e. 2016-18.

Diabetic Prevalence Rate in Adults: 12% of Overall Malaysian Population is suffering from diabetes in 2020. More than 18% Adults recorded Diabetes as on 2020, an increase from 11.2% in 2011, comparatively a higher proportion than other South East Asian Countries. Diabetes is a major health concern among Malaysians, and the prevalence of Type 2 diabetes (T2D) has escalated to more than 20% in adults above the age of 30 in 2020. Higher diabetic patients contributed to the growth of more patients who are suffering from Eye diseases like Diabetic Retinopathy, Cataract and Glaucoma.

Growing Share of Healthcare in GDP: GDP of Health Services in Private Sector increased from 8.0 Million in 2015 to around 12 Million in 2020P with a CAGR of 8.1% during 2015-20P whereas in Public Sector increased from 13.1 Million in 2015 to around 18.5 Million in 2020P with a CAGR of 7.2% during the same period. Gross Domestic Product (GDP) of health services provided an indication of the demand trends for health services including Ophthalmology Services in Public and Private Healthcare Settings in Malaysia.

Impact of COVID-19 on Malaysia Ophthalmology Market: COVID19 has severely impacted all the industries across the Globe. Eye related Elective Surgeries were stopped amidst the Movement Control Order (MCO) which was introduced by Federal Government of Malaysia to control COVID19 Pandemic effect on the Country. Guidelines were issued with respect to the Operations and Precautions to be followed across by the Ophthalmology Clinics. Guidelines majorly included timely Sterilization of Equipments, necessary Face Shields and Masks and Temperature Check of the Patient before they enter the clinic. Consultations and Surgeries declined in the Month of April, May and June as Customer footfall at the Clinics and Surgeries performed were reduced and only Patients with Severe Eye Problems could take the treatment.

Analysts at Ken Research in their latest publication “Malaysia Ophthalmology Market Outlook to 2025- Increase in Ophthalmic Surgeries & Consultations driven by Increasing Ageing Population Proportion and Ophthalmology Technological Advancements” observed that the Ophthalmology Market in Malaysia has been growing over the years as a result of Rising Number of Ophthalmologists, Growing Number of Clinics, Increasing Health Budget and Growth in Prevalence of Non Communicable Diseases such as Hypertension and Diabetes.

Malaysia Ophthalmology Market in terms of Number of Consultations and Number of Surgeries is expected to growth with a CAGR of 9.2% and 6.5% in the forecast period 2020-2025.

Key Segments Covered

Number of Consultations and Consultations Revenue

By Type of Specialty

Single Specialty Hospital/Clinic

Multi Specialty Hospital/Clinic

By Regions

Selangor

Kuala Lumpur

Johor

Perak

Penang

Others

By Ailment Type

Reduced Vision

Red Eyes

Eye Strain

General Check-Ups

Allergic Reactions

Deformities of Eye and Eye Lids

By Type of Clinic/Hospital

Public Hospitals/Clinics

Private Hospitals/Clinics

Number of Surgeries and Revenue from Surgeries

Type of Surgeries

Cataract

Refractive Error

Glaucoma

Retinal Disorders

Oculoplastic and Eye Lid Surgery

ARMD

Others

Malaysia Ophthalmology Market Companies Covered

ISEC Malaysia

Optimax Eye Specialist

Tunn Hussein Onn National Eye Hospital (THONEH)

Vista Eye Specialist

Top Vision Eye Specialist

Sunway Eye Centre

KPJ Centre for Sight

Oasis Eye Specialist

KL Eye Specialist

IKONIK Eye Specialist

Key Target Audience

Government and Regulatory Bodies

Industry Associations

Single Specialty Eye Clinics and Hospitals

Multi Specialty Eye Clinics and Hospitals

Eye Clinics

Ophthalmologists

Medical Device Companies

Ophthalmology Device Instrument Companies

Time Period Captured in the Report:-

Historical Period: 2015-2020

Forecast Period: 2021-2025

Key Topics Covered in the Report

Malaysia Ophthalmology Market Overview

Malaysia Ophthalmology Market Ecosystem

South East Asian Countries Ophthalmology Market Cross Comparison

Cross Comparison- Major Ophthalmology Players in Malaysia

Malaysia Ophthalmology Revenue Streams

Malaysia Ophthalmology Market Landscape

Malaysia Ophthalmology Market Size

Malaysia Ophthalmology Market Segmentations 2020

Malaysia Ophthalmology Market Growth Drivers

Malaysia Ophthalmology Market Government Regulations

Malaysia Ophthalmology Market Trends & Developments

Malaysia Ophthalmology Issues and Challenges

Malaysia Ophthalmology Market Major Company Profiles

Malaysia Ophthalmology Clinic Investment Model

Malaysia Ophthalmology Market Future Market Size and Segmentations, 2020-2025F

Covid-19 Impact on Malaysia Ophthalmology Market

Analyst Recommendations

Case Studies

For More Information on the Research Report, Refer to Below Link:

Ophthalmology Market in Malaysia

Related Reports

Philippines Ophthalmology (Eye Centers, Clinics and Hospital Chains) Market Outlook to 2023 – Investment Potential by Region and by Ailment Type (Cataract Surgery, Glaucoma Surgery, Refractive Error Surgery, Other Retina Related Surgeries and Others), Lasik & Aesthetics Centers

Indonesia Ophthalmology Market Outlook to 2023 – By Ailment Type (Cataract, Myopia, Glaucoma, Conjunctivitis and Others) and by Regions (DKI Jakarta, West Java, Central Java, North Sumatra and Others)

Vietnam Ophthalmology Market Outlook to 2023 – By Diseases (Cataract, Myopia, Glaucoma, Retina related Diseases, Blindness with Poor Eyesight, Conjunctivitis and Others), By Regions and By Hospitals (Single Specialty Eye Hospitals and Multi Specialty Hospitals)

Contact Us:

Ken Research

Ankur Gupta, Head Marketing & Communications

Ankur@kenresearch.com

+91-9015378249

Share.

Comments are closed.